The Altasciences Group Acquires Vince & Associates Clinical Research

The Altasciences Group acquired Vince & Associates Clinical Research, adding to its team providing comprehensive Phase I/IIa clinical drug development capabilities.

As part of the financing for the acquisition, the Altasciences Group entered into new credit facilities with a group of senior lenders led by Bank of Montreal as administrative agent and BMO Capital Partners (BMOCP) as mezzanine lender, and completed an equity financing with, among others, Investissement Québec.

Altasciences Company Inc., through its group of companies, provides comprehensive early stage clinical drug development services in Phase I/IIa, including the necessary support services in this critical stage of drug development. The Altasciences Group's majority shareholder is Kilmer Capital Partners. Kilmer Capital Partner is a leader in making private equity investments in mid-sized businesses undergoing periods of rapid growth, significant change or ownership transition.

Based in Overland Park, Kansas since 2001, Vince & Associates has become an established industry leader in the successful recruitment and retention of special populations in complex early development clinical trials.

The Altasciences Group was represented by Stikeman Elliott LLP with a team of John Leopold, Sophie Lamonde, Claire Zikovsky, Dana Borshy, Sarah Kingsley, Maxime Charbonneau, Allison Jaskolka (corporate); Howard Rosenoff, Lana Rabinovitch and Annick Gaucher-Paradis (banking); Luc Bernier, Roanne Bratz and Nicolas Désy (tax) and Tommy Ponte (corporate services). The Altasciences Group was advised with respect to US matters by Paul Hastings LLP with a team of William Simpson and Aref Afsari (corporate); Douglas Schaaf (tax); James Owens and Joshua Russell Hill (healthcare); Charles Patrizia and Devon Winkles (regulatory compliance); Mark Poerio and Damian Myers (employee benefits); Lindsay Sparks (banking) and Antonella Castro (real estate).

Vince & Associates was represented by Stinson Morrison Hecker LLP with a team of Victoria Westerhaus, Ashley Schoenjahn, Nick Hoffman (corporate); Kirk Doan (healthcare), Ben Hobert (tax), Steve Cosentino (intellectual property), Parthenia Evans (environmental), Patricia Konopka and Brooks Wood (employment) and Phil McKnight and Tom Brous (employee benefits).

Bank of Montreal was represented by Dentons Canada LLP with a team of Jane Bogaty, Barbara Farina and Maria Pavelis. BMOCP was represented by Fasken Martineau DuMoulin LLP with a team of Marc Novello, Martin Racicot and Svetlana Samochkine (banking and finance). The senior lenders and the mezzanine lender were advised with respect to US matters by Dentons US LLP with a team of Aimee Cummo and Michelle Alves. Investissement Québec was represented in-house by Bertrand Thibert, legal counsel, and by Norton Rose Fulbright Canada LLP with a team of Amar Leclair-Ghosh, Mathieu Deschamps, David Crandall and Emmanuel Grondin (M&A).


Lana Rabinovitch Sarah Kingsley Luc Bernier Martin Racicot Maxime Charbonneau Nicolas Désy Sophie Lamonde Barbara Farina Jane Bogaty Howard Rosenoff Dana Borshy Maria Pavelis Roanne Bratz Mathieu Deschamps Amar Leclair-Ghosh Claire Zikovsky Marc Novello John W. Leopold


Stikeman Elliott LLP Paul, Hastings, Janofsky & Walker LLP Stinson Morrison Hecker LLP Dentons Canada LLP Fasken Martineau DuMoulin LLP Norton Rose Fulbright Canada LLP